Lilly(Eli) & Co

NYSE:LLY   9:39:01 AM EDT
261.91
-0.56 (-0.21%)
Products, Regulatory

Lilly And Banner Alzheimer's Institute Collaborate On Planned Phase 3 Prevention Trial Of Donanemab

Published: 07/15/2021 14:17 GMT
Lilly(Eli) & Co (LLY) - Lilly and Banner Alzheimer's Institute Collaborate on Planned Phase 3 Prevention Trial of Donanemab.
Eli Lilly - Trailblazer-alz 3 Will Evaluate Whether Treatment With Donanemab Can Slow Clinical Progression of Alzheimer's Disease in Trial Participants.
Eli Lilly - Lilly Remains Sole Sponsor of Clinical Trial and Plans to Begin Enrollment Later This Year.